08:57 AM EDT, 04/08/2026 (MT Newswires) -- Health care stocks were steady premarket Wednesday, with the iShares Biotechnology ETF (IBB) inactive and the State Street Health Care Select Sector SPDR ETF (XLV) marginally declining.

GSK (GSK) shares were up more than 3% after the company said the Chinese National Medical Products Administration approved its biologic medication Exdensur as a supplemental therapy for adult patients suffering from chronic rhinosinusitis with nasal polyps.